Lwmg LLC Decreases Stock Position in The Procter & Gamble Company (NYSE:PG)

Lwmg LLC lowered its holdings in The Procter & Gamble Company (NYSE:PGFree Report) by 13.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,301 shares of the company’s stock after selling 198 shares during the quarter. Lwmg LLC’s holdings in Procter & Gamble were worth $225,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Exencial Wealth Advisors LLC boosted its position in Procter & Gamble by 13.1% in the fourth quarter. Exencial Wealth Advisors LLC now owns 16,250 shares of the company’s stock worth $2,381,000 after purchasing an additional 1,882 shares during the last quarter. CenterBook Partners LP boosted its stake in shares of Procter & Gamble by 48.0% during the 4th quarter. CenterBook Partners LP now owns 16,382 shares of the company’s stock worth $2,401,000 after acquiring an additional 5,311 shares during the last quarter. Waterloo Capital L.P. grew its position in shares of Procter & Gamble by 53.3% during the 4th quarter. Waterloo Capital L.P. now owns 6,276 shares of the company’s stock valued at $920,000 after acquiring an additional 2,181 shares during the period. Vermillion & White Wealth Management Group LLC purchased a new stake in shares of Procter & Gamble in the 4th quarter worth $62,000. Finally, Security National Bank bought a new position in Procter & Gamble in the 4th quarter worth $84,000. 65.77% of the stock is owned by institutional investors.

Procter & Gamble Trading Down 0.7 %

Shares of Procter & Gamble stock traded down $1.24 during trading on Friday, hitting $168.88. The stock had a trading volume of 6,003,668 shares, compared to its average volume of 6,670,893. The Procter & Gamble Company has a 12 month low of $141.45 and a 12 month high of $177.94. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.73 and a quick ratio of 0.53. The firm’s fifty day simple moving average is $171.15 and its 200-day simple moving average is $166.48. The stock has a market cap of $398.58 billion, a PE ratio of 27.59, a PEG ratio of 3.76 and a beta of 0.41.

Procter & Gamble (NYSE:PGGet Free Report) last announced its quarterly earnings data on Tuesday, July 30th. The company reported $1.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.37 by $0.03. The business had revenue of $20.53 billion during the quarter, compared to the consensus estimate of $20.69 billion. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The firm’s quarterly revenue was down .1% compared to the same quarter last year. During the same quarter last year, the firm earned $1.37 earnings per share. As a group, sell-side analysts expect that The Procter & Gamble Company will post 6.97 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Shareholders of record on Friday, July 19th were paid a $1.0065 dividend. The ex-dividend date of this dividend was Friday, July 19th. This represents a $4.03 dividend on an annualized basis and a yield of 2.38%. Procter & Gamble’s payout ratio is 65.69%.

Analyst Upgrades and Downgrades

PG has been the topic of several recent research reports. Deutsche Bank Aktiengesellschaft raised their price objective on Procter & Gamble from $171.00 to $176.00 and gave the stock a “buy” rating in a research note on Wednesday, July 17th. Stifel Nicolaus increased their price objective on shares of Procter & Gamble from $157.00 to $161.00 and gave the stock a “hold” rating in a research note on Monday, July 22nd. Piper Sandler initiated coverage on shares of Procter & Gamble in a report on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 target price for the company. Barclays downgraded Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price objective on the stock. in a research report on Monday, September 30th. Finally, Citigroup upped their price target on Procter & Gamble from $177.00 to $190.00 and gave the stock a “buy” rating in a research note on Wednesday, July 10th. Nine equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $175.89.

View Our Latest Research Report on PG

Insider Transactions at Procter & Gamble

In other Procter & Gamble news, CEO Jon R. Moeller sold 7,007 shares of the business’s stock in a transaction dated Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total value of $1,202,751.55. Following the completion of the sale, the chief executive officer now directly owns 269,172 shares of the company’s stock, valued at $46,203,373.80. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other Procter & Gamble news, insider Susan Street Whaley sold 450 shares of the stock in a transaction dated Tuesday, August 20th. The shares were sold at an average price of $169.22, for a total transaction of $76,149.00. Following the transaction, the insider now directly owns 13,072 shares in the company, valued at $2,212,043.84. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Jon R. Moeller sold 7,007 shares of the business’s stock in a transaction dated Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total transaction of $1,202,751.55. Following the completion of the sale, the chief executive officer now owns 269,172 shares of the company’s stock, valued at approximately $46,203,373.80. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 383,194 shares of company stock worth $65,140,718. 0.17% of the stock is currently owned by insiders.

About Procter & Gamble

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Recommended Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.